HSPA1A and amyotrophic lateral sclerosis: Hsp70 inducers/coinducers are generally convincing for ALS treatment (Kalmar et al., 2014; Kalmar and Greensmith, 2017), and it is especially true for arimoclomol (Phukan, 2010).